March 18, 2026 — RNews

#pneumococcal — Wednesday, March 18, 2026 (1 items)

hot top new

← prev day next day →

0

Safety, tolerability, and immunogenicity of a 31-valent pneumococcal conjugate vaccine (VAX-31) in healthy adults aged 50 years and older from the USA: a phase 1/2, double-blinded, active-controlled, parallel-group, dose-finding randomised clinical trial. (linkinghub.elsevier.com)

Wassil J … Sisti M Lancet Infectious Diseases 2026-03-18

#vaccination #clinical trial #immunogenicity #safety #pneumococcal